This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Bio-Reference Laboratories Inc (BRLI)

NASDAQ: Health Care

Company Balance Sheet
Oct 2013 Oct 2012 Oct 2011 Oct 2010
Cash and Equivalents 17.95M 25.14M 22.01M 17.78M
Receivables 206.26M 153.25M 148.06M 129.12M
Inventories 19.10M 14.90M 9.69M 6.19M
Other Current Assets 9.42M 5.37M 4.46M 2.82M
Total Current Assets 294.88M 223.58M 206.78M 172.80M
Property, Plant & Equipment, Gross 133.60M 102.70M 81.72M 67.25M
Accumulated Depreciation & Depletion 67.95M 52.26M 38.15M 30.42M
Property, Plant & Equipment, Net 65.65M 50.44M 43.57M 36.83M
Intangibles 16.32M 6.32M 6.90M 8.23M
Other Non-Current Assets 7.42M 6.80M 1.61M 2.91M
Total Non-Current Assets 126.65M 89.25M 76.48M 71.33M
Liabilities & Shareholder Equity
Total Assets 421.53M 312.82M 283.26M 244.13M
Accounts Payable 64.05M 41.29M 38.99M 36.97M
Short Term Debt 5.68M 4.42M 4.27M 3.76M
Other Current Liabilities 18.29M 9.75M 8.85M 6.68M
Total Current Liabilities 133.76M 71.95M 82.51M 83.34M
Long Term Debt 3.67M 4.16M 4.63M 3.32M
Deferred Income Taxes 0.00 0.00 0.00 0.00
Other Non-Current Liabilities 1.79M 0.00 0.00 750.00K
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 16.17M 13.63M 10.98M 8.40M
Total Liabilities 149.93M 85.58M 93.49M 91.74M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 271.60M 227.25M 189.77M 152.39M
Common Par 277.00K 277.00K 280.00K 278.00K
Additional Paid In Capital 39.43M 40.91M 45.58M 44.56M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings 231.89M 186.06M 143.91M 107.55M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments 0.00 0.00 0.00 0.00
Total Capitalization 275.26M 231.41M 194.39M 155.71M
Total Equity 271.60M 227.25M 189.77M 152.39M
Total Liabilities & Stock Equity 421.53M 312.82M 283.26M 244.13M
Total Common Shares Outstanding 27.68M 27.71M 27.95M 27.85M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 27.69M 27.74M 27.97M 27.79M
Diluted Weighted Shares Outstanding 27.85M 27.92M 28.21M 28.04M
Number of Employees 3338 2726 2438 1787
Number of Part-Time Employees 1089 838 717 637

BRLI Bio-Reference Laboratories Inc

Analysts Ratings for BRLI

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 0 0 1 1
Moderate Buy 0 0 0 0
Hold 1 1 1 1
Moderate Sell 1 1 0 0
Strong Sell 0 0 0 0

Brokerage Partners

BRLI Chatter

Select the service that is right for you!

Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs